Coya Therapeutics Inc. (NASDAQ: COYA)
$5.6100
-0.0400 ( -1.92% ) 45.9K
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
Market Data
Open
$5.6100
Previous close
$5.6500
Volume
45.9K
Market cap
$93.56M
Day range
$5.5200 - $5.9750
52 week range
$4.7500 - $10.6899
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Jan 13, 2025 |
| 4 | Insider transactions | 1 | Jan 13, 2025 |
| 4 | Insider transactions | 1 | Jan 13, 2025 |
| 4 | Insider transactions | 1 | Jan 13, 2025 |
| 4 | Insider transactions | 1 | Jan 03, 2025 |
| 4 | Insider transactions | 1 | Jan 03, 2025 |
| 4 | Insider transactions | 1 | Jan 03, 2025 |
| 4 | Insider transactions | 1 | Jan 03, 2025 |
| 4 | Insider transactions | 1 | Jan 03, 2025 |
| 424b3 | Other | 2 | Nov 29, 2024 |